Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Novartis
Argus Health
Harvard Business School
Queensland Health
Merck
Federal Trade Commission
Chubb
US Army
Teva

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,932,241

« Back to Dashboard

Which drugs does patent 7,932,241 protect, and when does it expire?

Patent 7,932,241 protects ZOMETA and RECLAST and is included in two NDAs.

Protection for RECLAST has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-six patent family members in twenty-two countries.
Summary for Patent: 7,932,241
Title:Pharmaceutical products comprising bisphosphonates
Abstract: A pharmaceutical product comprises a container containing a bisphosphonate solution, in which at least the internal surface of the container comprises a plastic material and in which the container is heat sterilisable, and which is in the form of a ready to use infusion solution, for administration of the bisphosphonate to a patient in need of bisphosphonate treatment.
Inventor(s): Glausch; Alexandra (Weil am Rhein, DE), Loffler; Rolf (Freiburg, DE), Sigg; Juergen (Loerrach, DE)
Assignee: Novartis AG (Basel, CH)
Application Number:10/570,339
Patent Claim Types:
see list of patent claims
Formulation; Compound; Process;

Drugs Protected by US Patent 7,932,241

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novartis ZOMETA zoledronic acid INJECTABLE;IV (INFUSION) 021223-003 Jun 17, 2011 AP RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Novartis RECLAST zoledronic acid INJECTABLE;IV (INFUSION) 021817-001 Apr 16, 2007 AP RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,932,241

PCT Information
PCT FiledSeptember 17, 2004PCT Application Number:PCT/EP2004/010470
PCT Publication Date:March 24, 2005PCT Publication Number: WO2005/025551

International Patents Family Members for US Patent 7,932,241

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 045670 ➤ Sign Up
Australia 2004271731 ➤ Sign Up
Brazil PI0414562 ➤ Sign Up
Canada 2536206 ➤ Sign Up
China 1852739 ➤ Sign Up
Colombia 5680461 ➤ Sign Up
Ecuador SP066419 ➤ Sign Up
European Patent Office 1663314 ➤ Sign Up
Israel 173766 ➤ Sign Up
Iceland 8351 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Cipla
Teva
Fuji
Covington
Argus Health
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot